Role of RGS12 in placental mitochondrial dysfunction and adverse pregnancy outcomes

Area of Science:

• Reproductive biology
• Mitochondrial biology
• Cellular signaling

Background:

• Placental mitochondrial function is vital for successful pregnancy.
• Dysregulation of mitochondrial pathways is linked to pregnancy complications.
• The specific molecular mechanisms underlying placental mitochondrial dysfunction remain incompletely understood.

Purpose of the Study:

• To investigate the role of Regulator of G-protein signaling 12 (RGS12) in placental mitochondrial function.
• To elucidate the impact of RGS12 on pregnancy outcomes.
• To identify RGS12 as a potential therapeutic target for pregnancy disorders.

Main Methods:

• Localization studies of RGS12 in human placental mitochondria.
• RGS12 knockdown experiments in human placental cells to assess mitochondrial function.
• In vivo studies using a mouse model of placental RGS12 deficiency.
• Analysis of placental samples from preterm birth (PTB) cases.

Main Results:

• RGS12 is localized in placental trophoblast mitochondria and enhances ATP5B activity via tyrosine phosphorylation.
• RGS12 deficiency in mice resulted in reduced tolerance to PTB challenge, decreased fetal weight, and trophoblast cell death.
• Impaired mitochondrial function, including diminished ATP synthase activity and p38MAPK pathway activation, was observed in RGS12-deficient placentas.
• Reduced RGS12 expression and mitochondrial dysfunction correlated with human PTB cases.

Conclusions:

• RGS12 plays a critical role in maintaining placental mitochondrial function and healthy pregnancy outcomes.
• RGS12 deficiency contributes to adverse pregnancy outcomes through mitochondrial dysfunction.
• RGS12 represents a potential novel therapeutic target for improving pregnancy health.